Edition:
United Kingdom

X T L Biopharmaceuticals Ltd (XTLB.OQ)

XTLB.OQ on NASDAQ Stock Exchange Capital Market

2.47USD
22 Nov 2017
Change (% chg)

-- (--)
Prev Close
$2.47
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,111
52-wk High
$4.69
52-wk Low
$1.93

Chart for

About

XTL Biopharmaceuticals Ltd. is a biopharmaceutical company. The Company focuses on the acquisition and development of pharmaceutical drugs for the treatment of medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action,... (more)
No analyst recommendations are available for .

Overall

Beta: -0.08
Market Cap(Mil.): $13.38
Shares Outstanding(Mil.): 5.14
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 89.23 16.44
EPS (TTM): -- -- --
ROI: -- 2.53 10.62
ROE: -- 3.17 14.20

Earnings vs. Estimates